Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Pirttilä

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|May 11, 2002
[Corticosteroids in the treatment of multiple sclerosis and optic neuritis]I Elovaara, T Pirttilä
Acta Neurologica Scandinavica|December 1, 1995
CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosisT Pirttilä, T Nurmikko
Acta Neurologica Scandinavica|June 13, 2008
Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's diseaseM A Korolainen, T Pirttilä
European Neurology|October 26, 1999
Coeliac disease presenting with neurological disordersL Luostarinen, T Pirttilä, P Collin
Neurology|April 11, 2001
CSF tau and Abeta42 levels in patients with Down's syndromeT Tapiola, H Soininen, T Pirttilä
Electrophoresis|January 1, 1990
Horizontal two-dimensional electrophoresis of cerebrospinal fluid proteins with immobilized pH gradients in the first dimensionK Mattila, T Pirttilä, H Frey
Acta Neurologica Scandinavica|January 1, 1991
CSF proteins in neurological disorders analyzed by immobilized PH gradient isoelectric focusing using narrow PH gradientsT Pirttilä, K Mattila, H Frey
Journal of the Neurological Sciences|February 1, 1992
The decrease of CD8-positive lymphocytes in Alzheimer's diseaseT Pirttilä, S Mattinen, H Frey
Neurochemistry International|January 4, 2001
Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionalityP Kerokoski, H Soininen, T Pirttilä
Acta Neurologica Scandinavica|April 15, 2004
Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALST Pirttilä, S Vanhatalo, U Turpeinen, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Duodecim; Laaketieteellinen Aikakauskirja|May 11, 2002
[Corticosteroids in the treatment of multiple sclerosis and optic neuritis]I Elovaara, T Pirttilä
Acta Neurologica Scandinavica|December 1, 1995
CSF oligoclonal bands, MRI, and the diagnosis of multiple sclerosisT Pirttilä, T Nurmikko
Acta Neurologica Scandinavica|June 13, 2008
Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's diseaseM A Korolainen, T Pirttilä
European Neurology|October 26, 1999
Coeliac disease presenting with neurological disordersL Luostarinen, T Pirttilä, P Collin
Neurology|April 11, 2001
CSF tau and Abeta42 levels in patients with Down's syndromeT Tapiola, H Soininen, T Pirttilä
Electrophoresis|January 1, 1990
Horizontal two-dimensional electrophoresis of cerebrospinal fluid proteins with immobilized pH gradients in the first dimensionK Mattila, T Pirttilä, H Frey
Acta Neurologica Scandinavica|January 1, 1991
CSF proteins in neurological disorders analyzed by immobilized PH gradient isoelectric focusing using narrow PH gradientsT Pirttilä, K Mattila, H Frey
Journal of the Neurological Sciences|February 1, 1992
The decrease of CD8-positive lymphocytes in Alzheimer's diseaseT Pirttilä, S Mattinen, H Frey
Neurochemistry International|January 4, 2001
Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionalityP Kerokoski, H Soininen, T Pirttilä
Acta Neurologica Scandinavica|April 15, 2004
Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALST Pirttilä, S Vanhatalo, U Turpeinen, et al.
Pageof 6